“We are excited to bring Maynard on board with the USO,” said Edward Reilly, Chairman of the USO Board of Governors. “His leadership, research and consulting experience will be a special asset to the USO as we expand our services to U.S. troops and their families.”
Dr. Maynard A. Howe, PhD, CEO and Vice Chairman of Stemedica Cell Technologies Inc.
Originally uploaded by Stemedica
“I’m honored and delighted to be a member of the USO Board of Governors,” said Dr. Howe. “I have always had a deep passion for supporting our dedicated soldiers. Joining the USO Board of Governors allows me to combine my passion, diverse contact base and medical knowledge in service to our troops.”
Dr. Howe is a sought after facilitator, lecturer and speaker. He holds a Bachelor of Science Degree in Business Management, Master of Science Degree in Educational and Counseling Psychology and a Doctorate in Clinical Psychology. He is the author and co-author of numerous articles and top selling business books. His book on quality, Quality on Trial, Bringing Customer Relationships into Focus, is in its second edition and has been published in several languages. Other books include a five-part implementation manual series, Business-to-Business Marketing Management System, published by McGraw-Hill.
About the USO The USO (United Service Organizations) lifts the spirits of America’s troops and their families. The USO provides a touch of home through centers at airports and military bases around the world, top quality entertainment and innovative programs and services tailored to meet troop needs. The USO also provides critical support to those who need us most, including forward-deployed troops and their families, wounded warriors and their families, and the families of the fallen. The USO is a private, non-profit organization, not a government agency; that relies on the generosity of our donors. For more information, please visit www.uso.org or contact Travis T. Burgin, USO, 703-740-4982.
About Stemedica Cell Technologies, Inc. Stemedica Cell Technologies Inc. (www.stemedica.com) is a specialty biopharmaceutical company that is committed to the development and manufacturing of best-in-class allogeneic adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and human stem cell clinical trials. The company is currently developing regulatory pathways for stroke and wound repair. Stemedica is headquartered in San Diego, California.
For more information regarding Stemedica Cell Technologies, Inc. contact Dave McGuigan at firstname.lastname@example.org.